These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30528383)

  • 1. Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A systematic review of cases.
    Warren N; Grote V; O'Gorman C; Siskind D
    Brain Stimul; 2019; 12(2):329-334. PubMed ID: 30528383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy: Literature Review and Future Directions.
    Tanguturi YC; Cundiff AW; Fuchs C
    Child Adolesc Psychiatr Clin N Am; 2019 Jan; 28(1):79-89. PubMed ID: 30389078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy.
    Moussa T; Afzal K; Cooper J; Rosenberger R; Gerstle K; Wagner-Weiner L
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):8. PubMed ID: 30777097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents and Young Adults With Anti-N-methyl-D-aspartate Receptor Encephalitis With Excited Catatonia: Literature Review and 2 Illustrative Cases.
    Levy E; Reinoso P; Shoaib H; Drucker J; Ashurova M; Sanghani S; Petrides G; Jimenez X
    J Acad Consult Liaison Psychiatry; 2023; 64(2):177-182. PubMed ID: 35948253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series.
    Wadi L; Mandge V
    J Neuroimmunol; 2024 Jan; 386():578271. PubMed ID: 38155066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive Therapy in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of the Literature.
    Coffey MJ; Cooper JJ
    J ECT; 2016 Dec; 32(4):225-229. PubMed ID: 27295461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT].
    Kanbayashi T; Tsutsui K; Tanaka K; Omori Y; Takaki M; Omokawa M; Mori A; Kusanagi H; Nishino S; Shimizu T
    Rinsho Shinkeigaku; 2014; 54(12):1103-6. PubMed ID: 25672720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Electroconvulsive Therapy in 2 Very Young Pediatric Patients With Catatonia Related to Anti-N-methyl-D-aspartate Receptor Encephalitis.
    Cooper JJ; Afzal KI
    J ECT; 2019 Sep; 35(3):216-217. PubMed ID: 30720552
    [No Abstract]   [Full Text] [Related]  

  • 9. A Case of Anti-NMDA Receptor Encephalitis Treated with ECT.
    Jones KC; Schwartz AC; Hermida AP; Kahn DA
    J Psychiatr Pract; 2015 Sep; 21(5):374-80. PubMed ID: 26348805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis.
    Warren N; Siskind D; O'Gorman C
    Acta Psychiatr Scand; 2018 Nov; 138(5):401-408. PubMed ID: 29992532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment.
    Wilson JE; Shuster J; Fuchs C
    Psychosomatics; 2013; 54(6):585-9. PubMed ID: 23849593
    [No Abstract]   [Full Text] [Related]  

  • 12. Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review.
    Marques Macedo I; Gama Marques J
    CNS Spectr; 2020 Aug; 25(4):475-492. PubMed ID: 31663486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis and catatonia as presenting features of anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis.
    Chatterjee SS; Ghosal MK; Mitra S
    Asian J Psychiatr; 2017 Jun; 27():112. PubMed ID: 28558879
    [No Abstract]   [Full Text] [Related]  

  • 14. Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis.
    Kim S; Horiuchi K; Ueda T; Boku S
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38307623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ECT in autoimmune encephalitis].
    Waaler HO; Harbo T
    Ugeskr Laeger; 2021 Jan; 183(3):. PubMed ID: 33491641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Catatonia Due to N-methyl-D-Aspartate Receptor Encephalitis Responsive to Electroconvulsive Therapy: The Clinical Use of the Clock Drawing Test.
    Medina M; Cooper JJ
    J ECT; 2017 Dec; 33(4):223-224. PubMed ID: 28658010
    [No Abstract]   [Full Text] [Related]  

  • 17. Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature.
    Wright MA; Guasp M; Lachner C; Day GS; Gombolay G; Titulaer MJ; Clardy SL
    J Neuroimmunol; 2024 Jul; 392():578369. PubMed ID: 38823118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete cognitive recovery in a severe case of anti-N-methyl-d-aspartate receptor encephalitis treated with electroconvulsive therapy.
    Leding C; Marstrand L; Jorgensen A
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32034002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
    Olaleye KT; Oladunjoye AO; Otuada D; Anugwom GO; Basiru TO; Udeogu JE; Opaleye-Enakhimion T; Espiridion ED
    Cureus; 2021 Jun; 13(6):e15706. PubMed ID: 34277291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Refractory Dyskinesia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Electroconvulsive Therapy.
    Sunwoo JS; Jung DC; Choi JY; Kang UG; Lee ST; Lee SK; Chu K
    J ECT; 2016 Sep; 32(3):e13-4. PubMed ID: 26959858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.